Ligence Heart vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Ligence
VS
by Volta Medical

AI Verdict

Ligence Heart is designed for automating echocardiography analysis and reporting to enhance diagnostic efficiency for cardiologists and sonographers. In contrast, VX1+ provides real-time AI-driven assistance to electrophysiologists during cardiac ablation procedures for atrial fibrillation and tachycardia. Therefore, while both are cardiology AI tools, they address distinct clinical needs and stages of patient care.

Choose Ligence Heart if…

Choose Ligence Heart if your primary need is to streamline and enhance the diagnostic process for 2D transthoracic echocardiography. This tool is ideal for cardiology departments aiming to automate image analysis, generate comprehensive reports efficiently, and improve the accuracy of disease recognition for conditions like heart failure or valvular diseases. It's best suited for optimizing the workflow of sonographers and cardiologists in interpreting echo studies.

View Ligence Heart →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist seeking real-time, AI-powered assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to identify abnormal electrograms and provide crucial insights directly within the operating room, helping to guide catheter placement and improve the efficacy of ablation. It integrates with existing EP recording and 3D mapping systems to enhance procedural outcomes.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ligence Heart VX1+
Pricing Contact-for-pricing Unknown
Deployment Cloud-based; on-premise; hybrid Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart is a web-based platform that automates significant portions of echocardiography analysis and report generation, suggesting a streamlined and accessible user experience for a broader range of users. It also provides training videos to operators prior to access. While VX1+ emphasizes a simple user interface with color coding for real-time assistance, its specialized procedural context and integration with specific EP systems suggest a more niche user base and setup.

Clinical Value

VX1+

Both tools demonstrate significant clinical value backed by studies. Ligence Heart enhances diagnostic accuracy and efficiency for a wide range of common cardiac conditions through automated echocardiography analysis, with studies showing strong agreement with gold standards and expert measurements. However, VX1+ provides real-time AI guidance during complex, invasive cardiac ablation procedures for specific arrhythmias like atrial fibrillation, with clinical evidence suggesting standardization of outcomes and high freedom from arrhythmia. This real-time, intra-procedural impact on interventional patient care gives VX1+ a slight edge in direct clinical impact.

Pricing & Value

Ligence Heart

Both tools lack publicly available pricing, making a direct comparison of their value proposition challenging. However, Ligence Heart explicitly invites potential customers to 'contact vendor for pricing, demos, and trial information,' suggesting a more transparent initial engagement process for assessing value. VX1+ simply states pricing is 'not publicly available' without offering similar explicit avenues for inquiry.

Enterprise Readiness

Ligence Heart

Ligence Heart explicitly states HIPAA compliance, BAA availability, and offers flexible deployment options including cloud, on-premise, and hybrid, with integration into common hospital systems like PACS, EHR, and RIS. While VX1+ has FDA clearance and integrates with specific EP systems, its HIPAA and BAA status are only inferred as 'expected' rather than explicitly stated. Ligence Heart's explicit compliance declarations and broader integration/deployment flexibility make it demonstrably more enterprise-ready.

Innovation

VX1+

Both tools are innovative in their respective domains. Ligence Heart brings significant innovation by automating and enhancing the efficiency and accuracy of a widely used diagnostic imaging modality. However, VX1+ stands out for its real-time AI assistance during complex, invasive cardiac ablation procedures, directly guiding electrophysiologists during a live intervention. This real-time, intra-procedural application of AI represents a more advanced and potentially transformative innovation in interventional cardiology.

Support & Docs

Ligence Heart

Ligence Heart explicitly provides an email for technical support, offers user manuals in multiple languages on its website, and mentions release notes and a software installation manual. While VX1+ also has a user manual, Ligence Heart demonstrates a more comprehensive and transparent approach to support and documentation through its explicit contact information and readily available resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ligence Heart VX1+
Name Ligence Heart VX1+
Company Ligence Volta Medical
Description AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Primary Specialty Cardiology Cardiology
Key Features Automated recognition of echocardiography imaging data; Automated view classification and heart phase prediction; Automated calculation of measurements and report generation; Transfer of echocardiography images (PHI removed) from hospital PACS; Area, Distance, Doppler, and Volume quantification; Disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases); Automated strain, Spectral and Tissue Doppler measurements; Integration with existing systems (PACS, EHR, RIS) Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures; AI-driven insights to assist electrophysiologists during ablation procedures; Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system); Non-sterile reusable medical device; Simple user interface with color coding for electrogram dispersion (blue, orange, red); Booster mode for increased sensitivity during AT or slow AF; Provides cycle length estimation from electrograms

Videos

Demos, reviews, and walkthroughs featuring Ligence Heart and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Ligence Heart is an AI-powered web-based platform designed to automate the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. It includes disease recognition for conditions such as heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases. VX1+ is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Ligence Heart integrates with existing systems such as PACS, EHR, and RIS, and facilitates the transfer of echocardiography images (with PHI removed) from hospital PACS. VX1+ is a software application on a computing platform that integrates with existing EP recording and 3D mapping systems, including specific compatibility with systems like Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
Ligence Heart provides automated recognition of echocardiography imaging data, view classification, heart phase prediction, calculation of measurements (Area, Distance, Doppler, Volume, strain, Spectral and Tissue Doppler), and report generation, along with disease recognition. VX1+ offers real-time manual or automatic annotation of 3D anatomical and electrical maps, identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, and provides cycle length estimation from electrograms.
Ligence Heart has received U.S. Food and Drug Administration (FDA) 510(k) clearance, is HIPAA compliant, and the company provides a Business Associate Agreement (BAA). VX1+ is FDA cleared; while HIPAA compliance and a BAA are not explicitly stated, they are expected for a medical device handling patient data in U.S. healthcare settings.
AI Tool Finder
AI-powered search. Results may not be comprehensive.